Giant Cell Arteritis

Giant Cell Arteritis is a serious condition that affects the arteries, especially the ones in your head and neck. It's more common in older adults. Symptoms can include fever, fatigue, headache, vision problems, and jaw pain. It's important to get it checked out quickly if you have these symptoms.

Condition

What people with Giant Cell Arteritis report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Giant Cell Arteritis?

NameHow it went

About Giant Cell Arteritis

What It Is

Giant cell arteritis (GCA) is inflammation of the walls of medium and large arteries, most often the arteries of the scalp and head. It is also called temporal arteritis because the arteries running over the temples are commonly involved. As an inflamed artery swells, it can narrow and reduce blood flow to the tissue it supplies, including the eye. The most common symptom is a new headache, often around the temples, sometimes with a tender scalp that hurts when brushing hair. Many people also have jaw pain when chewing, fatigue, fever, poor appetite or weight loss. GCA matters because reduced blood flow to the optic nerve can cause sudden vision loss that is usually permanent, so it is treated as an urgent condition rather than a routine headache. GCA can also affect the aorta, the body's main artery, and its large branches. About half of people with GCA also have polymyalgia rheumatica, a related inflammatory condition that causes aching and stiffness in the shoulders and hips.

Causes & Risk Factors

GCA happens when the immune system attacks the walls of arteries, but why that attack starts in a particular person is not known. Age is the clearest risk factor: the condition almost never occurs before 50, and the average age at diagnosis is in the early 70s. Women are affected two to three times as often as men, and it is most common in people of northern European, especially Scandinavian, ancestry. People who have polymyalgia rheumatica are at higher risk of developing GCA, either at the same time or later. Nothing a person did is known to cause it.

How It's Diagnosed

Diagnosis starts with symptoms and an examination. A clinician may find a tender, thickened temporal artery with a weak pulse, and checks vision and the eyes. Because waiting can risk vision, treatment with steroids is often started on suspicion, before every test is back. Blood tests measure inflammation. The erythrocyte sedimentation rate (ESR, or sed rate) records how quickly red blood cells settle in a tube, and C-reactive protein (CRP) is a protein the liver makes during inflammation. Most people with GCA have raised levels, and normal results make it less likely. High levels do not prove GCA, though, because infections and many other conditions raise them too. The usual way to confirm the diagnosis in the United States is a temporal artery biopsy: a short piece of the artery at the temple is removed under local anesthetic and examined for inflammation. It is best done within about two weeks of starting steroids, and a longer sample is more reliable because the inflammation can skip sections of the artery. A negative biopsy does not fully rule GCA out. Ultrasound of the temple arteries is used in some experienced centers, and blood vessel scans such as computed tomography (CT) or magnetic resonance (MR) angiography can look for inflammation in the aorta and other large arteries.

Treatment Options

The first treatment is a high dose of a corticosteroid (a steroid that calms inflammation), usually prednisone tablets, started as soon as GCA is suspected. Headache and other symptoms often ease within a few days. When vision is already threatened, steroids may first be given through a vein at a higher dose. Steroids protect against further damage, but vision that has already been lost usually does not come back. Once symptoms are controlled, the dose is lowered gradually over many months. Many people need some prednisone for one to two years, and long courses bring well-known side effects: bone thinning, raised blood sugar, weight gain, poor sleep, mood changes, cataracts and easy bruising. A bone density test and calcium, vitamin D or bone-protecting medicine are often part of the plan. To shorten steroid use and reduce flares, a steroid-sparing medicine is often added. Tocilizumab (Actemra), an injection or infusion that blocks interleukin-6, a signaling protein that drives the inflammation, was the first approved for GCA. In its main trial, about half the people taking it with a six-month steroid taper stayed in remission for a year, compared with fewer than one in five on steroids alone. Upadacitinib (Rinvoq), a daily tablet that blocks Janus kinase (JAK) enzymes, which relay several inflammatory signals, is also approved for GCA after a 2025 trial showed a steroid-sparing benefit. Both lower the body's defenses, so serious infections are the main trade-off, and screening for tuberculosis is done before starting. Methotrexate, an older immune-suppressing tablet, is a less effective but cheaper option for people who cannot use these medicines. People whose GCA has narrowed the carotid or vertebral arteries (the arteries supplying the brain) may also be advised to take aspirin.

What to Expect

With prompt treatment, GCA can be brought under control, and many people eventually stop treatment entirely. The early weeks are often dominated by the effects of high-dose steroids rather than the disease itself. Flares are common as steroids are tapered. They may show up as returning headache, jaw pain or shoulder and hip stiffness, and are usually managed by adjusting the dose or adding a steroid-sparing medicine. A rise in blood inflammation markers without symptoms is not, on its own, a reason to increase treatment, but it may lead to closer checks. Regular follow-up continues for years, even in remission. Visits review symptoms, blood tests, steroid side effects and bone health. Because GCA can quietly affect the aorta, imaging may be used to check for bulging (aneurysm) or narrowing of large arteries, which can appear years after diagnosis. People who lost vision before treatment usually find that the remaining vision stays stable once steroids start, and low-vision support can help with daily independence.

When to Seek Help

If you are over 50 and develop a new headache, scalp tenderness, or jaw pain when chewing, especially with fatigue or fever, get seen by a clinician the same day rather than waiting for a routine appointment. People with polymyalgia rheumatica should report these symptoms promptly too. If you are being treated for GCA, contact your care team soon if old symptoms return as your dose is lowered, or if you develop fever or other signs of infection while taking steroids or a steroid-sparing medicine. Sudden blurring, dimming or loss of vision in either eye, or new double vision, needs emergency assessment right away, because vision loss from GCA is usually permanent and can spread to the other eye. Call 911 for signs of a stroke, such as sudden weakness or numbness on one side, trouble speaking or sudden loss of balance.

Questions to Ask Your Doctor

  1. 1.How sure are we that this is giant cell arteritis, and do I need a biopsy or scans to confirm it?
  2. 2.What is the plan for lowering my steroid dose, and what symptoms would mean it is going too fast?
  3. 3.Would adding tocilizumab, upadacitinib or methotrexate help me use less prednisone, and what are the trade-offs for me?
  4. 4.How will we protect my bones, blood sugar and eyes while I am on steroids?
  5. 5.Should my aorta and other large arteries be checked with imaging, and how often?

Last reviewed • Oct 2026

Educational content, not medical advice.